Deryugina E I, Bourdon M A, Reisfeld R A, Strongin A
La Jolla Institute for Experimental Medicine, La Jolla, California 92037, USA.
Cancer Res. 1998 Aug 15;58(16):3743-50.
We assessed the functional significance of tumor cell-associated matrix metalloproteinase (MMP)-2 in extracellular matrix remodeling compared with that of the soluble enzyme by evaluating the contraction of three-dimensional collagen lattices by human glioma U251.3 and fibrosarcoma HT-1080 cell lines. In this model, the constitutive synthesis and activation of the MMP-2 proenzyme were modulated by stable transfections of tumor cells with cDNA encoding membrane type 1-MMP (MT1-MMP). The efficiency of transfected cells in contracting collagen lattices was shown to be dependent on the MT1-MMP-mediated activation of MMP-2 accompanied by cell surface association of activated MMP-2, on the cell-matrix interactions controlled by collagen-specific integrins, and on the integrity of actin and microtubule cytoskeletons. Each one of these mechanisms was essential but was not sufficient by itself in accomplishing gel contraction by MT1-MMP-transfected cells. Both MMP-2 activation and gel contraction by transfected glioma cells were inhibited by tissue inhibitor of metalloproteinase (TIMP)-2 and the recombinant COOH-terminal domain of MMP-2. However, the kinetics and mechanisms of their inhibitory effects were different, because TIMP-2 and the COOH-terminal domain of MMP-2 preferentially inhibited the MT1-MMP-dependent and autocatalytic steps of MMP-2 activation, respectively. By contrast, TIMP-1, an efficient inhibitor of soluble MMP-2 activity, failed to affect gel contraction. In addition, soluble MMP-2 activated by either organomercurials or cells was not able to induce the contraction of collagen lattices when added to transfected cells. Therefore, soluble activated MMP-2, sensitive to TIMP-1 inhibition, does not mediate collagen gel contraction by tumor cells, whereas the activity of cell surface-associated MMP-2 plays a critical role in remodeling of the extracellular matrix in vitro. These mechanisms of functional and spatial regulation of MMP-2 may also be applicable to different aspects of tissue reorganization in vivo, including cell migration and invasion, angiogenesis, and wound healing.
我们通过评估人胶质瘤U251.3和纤维肉瘤HT - 1080细胞系对三维胶原晶格的收缩情况,比较了肿瘤细胞相关基质金属蛋白酶(MMP)-2与可溶性酶在细胞外基质重塑中的功能意义。在该模型中,通过用编码膜型1 - MMP(MT1 - MMP)的cDNA稳定转染肿瘤细胞,调节MMP - 2酶原的组成型合成和激活。结果显示,转染细胞收缩胶原晶格的效率取决于MT1 - MMP介导的MMP - 2激活以及激活的MMP - 2在细胞表面的结合,取决于胶原特异性整合素控制的细胞 - 基质相互作用,还取决于肌动蛋白和微管细胞骨架的完整性。这些机制中的每一种都是必不可少的,但仅凭自身不足以使MT1 - MMP转染细胞完成凝胶收缩。转染的胶质瘤细胞的MMP - 2激活和凝胶收缩均受到金属蛋白酶组织抑制剂(TIMP)-2和MMP - 2重组COOH末端结构域的抑制。然而,它们抑制作用的动力学和机制不同,因为TIMP - 2和MMP - 2的COOH末端结构域分别优先抑制MMP - 2激活的MT1 - MMP依赖性步骤和自催化步骤。相比之下,可溶性MMP - 2活性的有效抑制剂TIMP - 1未能影响凝胶收缩。此外,用有机汞或细胞激活的可溶性MMP - 2添加到转染细胞中时,不能诱导胶原晶格的收缩。因此,对TIMP - 1抑制敏感的可溶性激活MMP - 2不介导肿瘤细胞的胶原凝胶收缩,而细胞表面相关MMP - 2的活性在体外细胞外基质重塑中起关键作用。MMP - 2的这种功能和空间调节机制也可能适用于体内组织重组的不同方面,包括细胞迁移和侵袭、血管生成以及伤口愈合。